Docoh
Loading...

38 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
20 Sep 21
Definitive proxy
2:51pm
adversely impact our ability to achieve these goals. In short, if our stockholders do not approve this proposal, we may not be able to access the capital
PRE 14A
PCSA Processa Pharmaceuticals Inc
1 Sep 21
Preliminary proxy
4:46pm
impact our ability to achieve these goals. In short, if our stockholders do not approve this proposal, we may not be able to access the capital markets
10-Q
2021 Q2
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
,” or other similar words and phrases. Similarly, statements herein that describe the Company’s objectives, plans or goals also are forward-looking
10-Q
2021 Q1
PCSA Processa Pharmaceuticals Inc
13 May 21
Quarterly report
4:30pm
that describe the Company’s objectives, plans or goals also are forward-looking statements. Actual results could differ materially from those projected
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
of individual and corporate objectives; provide for short-term, medium-term and long-term financial and strategic goals; and align the interest … complementary goals of the Omnibus Plan are to attract and retain outstanding individuals to serve as our officers, directors, employees
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
for short-term, medium-term and long-term financial and strategic goals; and align the interest of management with those of the stockholders by providing … goals of the Omnibus Plan are to attract and retain outstanding individuals to serve as our officers, directors, employees and consultants
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions
10-Q
2020 Q3
PCSA Processa Pharmaceuticals Inc
12 Nov 20
Quarterly report
4:01pm
,” or other similar words and phrases. Similarly, statements herein that describe the Company’s objectives, plans or goals also are forward-looking statements
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
stock to eligible participants. The two complementary goals of the Omnibus Plan are to attract and retain outstanding individuals to serve as our … ) the grant, purchase, or exercise price with respect to any award; and (D) the performance goals of an award. In any such case, the Administrator may also
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
that provides us with the authority to issue up to 500,000 shares of our common stock to eligible participants. The two complementary goals … ) the performance goals of an award. In any such case, the Administrator may also provide for a cash payment to the holder of an outstanding award
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
that provides us with the authority to issue up to 500,000 shares of our common stock to eligible participants. The two complementary goals … ) the performance goals of an award. In any such case, the Administrator may also provide for a cash payment to the holder of an outstanding award
S-1/A
EX-10.5
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
to receive a cash payment to the extent Performance Goals are achieved as described in Section 10. (h) “Cause” has the meaning given … ) “Performance Goals” means any objective or subjective goals selected by the Administrator to measure the level of performance and determine the payout
S-1/A
EX-10.1
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options may vary. The provisions of this Section
S-1/A
EX-10.11
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
’ activities under this Agreement to the extent provided in this Agreement. The PCYU Board shall: (i) oversee the Development Plan to ensure that the goals
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
under this Agreement to the extent provided in this Agreement. The PCYU Board shall: (i) oversee the Development Plan to ensure that the goals
10-Q
2020 Q2
PCSA Processa Pharmaceuticals Inc
5 Aug 20
Quarterly report
3:32pm
or goals also are forward-looking statements. Actual results could differ materially from those projected, implied or anticipated by the Company’s
10-Q
2020 Q1
PCSA Processa Pharmaceuticals Inc
15 May 20
Quarterly report
1:23pm
that describe the Company’s objectives, plans or goals also are forward-looking statements. Actual results could differ materially from those projected
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all
10-Q
2019 Q3
PCSA Processa Pharmaceuticals Inc
14 Nov 19
Quarterly report
11:45am
objectives, plans or goals also are forward-looking statements. Actual results could differ materially from those projected, implied or anticipated
10-Q
2019 Q2
PCSA Processa Pharmaceuticals Inc
13 Aug 19
Quarterly report
8:00pm
. Similarly, statements herein that describe the Company’s objectives, plans or goals also are forward-looking statements. Actual results could differ